L076-VISN 10 - Online Clinical Drug Information

The purpose of this solicitation amendment is to address questions received from industry prior to the Q&A deadline and to extend the solicitation closing date. During its market research, did the agency identify any SDVOSBs that develop, own, and/or operate the SaaS platform being solicited? During market research, the Government identified two or more SDVOSBs that stated they would provide a quote for services; however, the firms indicated they would function as reseller Prime Contractors. Will the agency provide a breakdown of what constitutes the amount paid by the Government for contract performance under FAR 52.219 14(e)(1) (e.g., implementation, hosting, training, etc.), and clarify whether such amounts include SaaS licensing fees paid by the Government? Applicable fees under FAR 52